Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 180

The DOI matches its Crossref record.

MicroRNA-1258 Suppresses Breast Cancer Brain Metastasis by Targeting Heparanase

Open access
Zhang, Lixin, Sullivan, Peggy S., Goodman, Jerry C., Gunaratne, Preethi H., Marchetti, Dario · 2011 · Cancer Research

Published version of a preprint

Abstract

Heparanase (HPSE) is a potent protumorigenic, proangiogenic, and prometastatic enzyme that is overexpressed in brain metastatic breast cancer (BMBC). However, little is known about the regulation of this potential therapeutic target in BMBC, which remains very poorly managed in the clinic. We hypothesized that HPSE gene expression might be regulated by micro RNA that might be exploited therapeutically. Using miRanda and RNAhybrid, we identified miR-1258 as a candidate micro RNA that may directly target HPSE and suppress BMBC. In support of our hypothesis, we found that miR-1258 levels inversely correlated with heparanase expression, enzymatic activity, and cancer cell metastatic propensities, being lowest in highly aggressive BMBC cell variants compared with either nontumorigenic or nonmetastatic human mammary epithelial cells. These findings were validated by analyses of miR-1258 and heparanase content in paired clinical specimens of normal mammary gland versus invasive ductal carcinoma, and primary breast cancer versus BMBC. In regulatory experiments, miR-1258 inhibited the expression and activity of heparanase in BMBC cells, whereas modulating heparanase blocked the phenotypic effects of miR-1258. In functional experiments, stable expression of miR-1258 in BMBC cells inhibited heparanase in vitro cell invasion and experimental brain metastasis. Together, our findings illustrate how micro RNA mechanisms are linked to brain metastatic breast cancer through heparanase control, and they offer a strong rationale to develop heparanase-based therapeutics for treatment of cancer patients with brain metastases, BMBC in particular. Cancer Res; 71(3); 645–54. ©2011 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-10-1910

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 20

  1. Palmieri, 2007, The biology of metastasis to a sanctuary site, Clin Cancer Res, 13, 1656, 10.1158/1078-0432.CCR-06-2659 · DOI
  2. Ilan, 2006, Regulation, function, and clinical significance of heparanase in cancer metastasis and angiogenesis, Int J Biochem Cell Biol, 38, 2018, 10.1016/j.biocel.2006.06.004 · DOI · Paper page
  3. Zcharia, 2008, Newly generated heparanase knockout mice unravel co-regulation of heparanase and matrix metalloproteinases, PLoS ONE, 4
  4. Zhang, 2010, EGF – induced heparanase nucleolar localization augments DNA Topoisomerase I activity in brain metastatic breast cancer, Molecular Cancer Res, 8, 278, 10.1158/1541-7786.MCR-09-0375 · DOI
  5. Marchetti, 2000, Astrocytes contribute to the brain-metastatic specificity of melanoma cell by producing heparanase, Cancer Res, 60, 4767
  6. Murry, 2006, Heparanase mechanisms of melanoma metastatic to the brain: Development and use of a brain slice model, J Cell Biochem, 97, 217, 10.1002/jcb.20714 · DOI
  7. Marchetti, 2001, Human heparanase: A molecular determinant of brain metastasis, Adv Enzyme Reg, 41, 343, 10.1016/S0065-2571(00)00016-9 · DOI
  8. Chen, 2005, MicroRNAs as oncogenes and tumor suppressors, New Engl J Med, 353, 1768, 10.1056/NEJMp058190 · DOI · Paper page
  9. Tavazoie, 2008, Endogenous human microRNAs that suppress breast cancer metastasis, Nature, 451, 147, 10.1038/nature06487 · DOI · Paper page
  10. Valastyan, 2009, A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis, Cell, 137, 1032, 10.1016/j.cell.2009.03.047 · DOI · Paper page
  11. Sachdeva, 2010, MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin1, Cancer Res, 70, 378, 10.1158/0008-5472.CAN-09-2021 · DOI · Paper page
  12. Creighton, 2010, Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers, Cancer Res, 70, 1906, 10.1158/0008-5472.CAN-09-3875 · DOI · Paper page
  13. Kim, 2004, Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastasis in nude mice, Clin Exp Met, 21, 107, 10.1023/B:CLIN.0000024761.00373.55 · DOI · Paper page
  14. Rehmsmeier, 2004, Fast and effective prediction of microRNA/target duplexes, RNA, 10, 1507, 10.1261/rna.5248604 · DOI · Paper page
  15. Kloosterman, 2006, In situ detection of miRNA in animal embryos using LNA-modified oligonucleotide probes, Nat Methods, 3, 27, 10.1038/nmeth843 · DOI · Paper page
  16. Carson, 2005, A method for automated detection of gene expression required for the establishment of a digital transcriptome-wide gene expression atlas, J Microsc, 217, 275, 10.1111/j.1365-2818.2005.01450.x · DOI
  17. Imada, 2006, COX-2 induction by heparanase in the progression of breast cancer, Int J Mol Med, 17, 221
  18. Cohen-Kaplan, 2008, Heparanase auguments epidermal growth factor receptor phosphorylation: Correlation with head and neck tumor progression, Cancer Res, 68, 10077, 10.1158/0008-5472.CAN-08-2910 · DOI
  19. Cohen, 2006, Heparanase prompts growth, angiogenesis, and survival of primary breast tumors, Int J Cancer, 118, 1609, 10.1002/ijc.21552 · DOI
  20. Edovitsky, 2004, Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis, J. Natl Cancer Inst, 96, 1219, 10.1093/jnci/djh230 · DOI · Paper page

Cited by

See all 180

Metadata

Authors
Zhang, L., Sullivan, P. S., Goodman, J. C., Gunaratne, P. H., & Marchetti, D.
Venue
Cancer Research
Published
2011-02-01
Volume
71
Issue
3
Pages
645-654
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2018110352
Cited by
180
References
0
FWCI
5.00
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MicroRNA-1258 Suppresses Breast Cancer Brain Metastasis by Targeting Heparanase. https://app.cochat.ai/papers/10.1158/0008-5472.can-10-1910
The paper
Zhang, L., Sullivan, P. S., Goodman, J. C., Gunaratne, P. H., & Marchetti, D. (2011). MicroRNA-1258 Suppresses Breast Cancer Brain Metastasis by Targeting Heparanase. Cancer Research. https://doi.org/10.1158/0008-5472.can-10-1910

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.